{
    "Trade/Device Name(s)": [
        "BD Veritor System for Rapid Detection of Flu A+B CLIA-Waived Kit",
        "BD Veritor System",
        "BD Veritor System Flu A+B"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K223016",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112277",
        "K132259",
        "K132692",
        "K151291",
        "K160161",
        "K180438"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PSZ"
    ],
    "Summary Letter Date": "September 27, 2022",
    "Summary Letter Received Date": "September 29, 2022",
    "Submission Date": "September 27, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.3328"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Antigen Detection Test System",
        "Devices Detecting Influenza A, B, and C Virus Antigens"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Flexible minitip flocked swab",
        "Reaction tube prefilled with lysing agent"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Veritor Plus Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Immuno-chromatographic assay",
        "Digital reflectance-based measurement"
    ],
    "Methodologies": [
        "Direct qualitative detection",
        "Antigen detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Analyzer",
        "Instrument",
        "Control",
        "Reagent",
        "Accessory",
        "Verification cartridge",
        "Swab"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System for Rapid Detection of Flu A+B CLIA-Waived Kit using chromatographic immunoassay and BD Veritor Plus Analyzer for detection of influenza A and B viral nucleoprotein antigens",
    "Indications for Use Summary": "Aids in the diagnosis of influenza A and B viral infections in symptomatic patients by direct and qualitative detection of influenza A and B viral nucleoprotein antigens from nasal and nasopharyngeal swabs; negative results are presumptive and require confirmation by viral culture or FDA-cleared molecular assay; not intended to detect influenza C antigens",
    "fda_folder": "Microbiology"
}